PCBL

- PCBL Chemical Limited submitted its Business Responsibility and Sustainability Report (BRSR) for Financial Year 2025-26, along with an Assurance Report by M/s Forvis Mazars. - For FY 2025-26, the company reported a Revenue from Operations of ₹5,576.05 Crores and a Net worth of ₹3,692.15 Crores. - Exports contributed 33.98% to the total turnover. - All stakeholder complaints (Shareholders, Employees, Customers) for FY 2025-26 were resolved. - The report identifies opportunities with positive financial implications in GHG emissions, energy, water, solid waste management, and circularity.

- PCBL Chemical Limited announced the appointment of Mr. Rohit Maindwal as Chief & Executive Director – Specialty Blacks and Senior Management Personnel, effective August 20, 2026. - He brings 32 years of industry experience, including tenure with Reliance Industries Limited.

- PCBL Chemical received approval under the ECMS for its Acetylene Black Project. - Proposed investment is approximately ₹329 crore. - The project aims to develop the domestic advanced materials ecosystem, strengthen supply chains, reduce import dependence, and generate employment.

- Q1 FY27 saw consolidated revenue up 17% YoY to ₹2,474 Cr, EBITDA up 23% YoY to ₹400 Cr, and PAT up 65% YoY to ₹155 Cr. Specialty sales volume grew 23% YoY. - Outlook remains positive with expected good volume growth for FY27, despite temporary Q2 moderation due to cautious customer procurement. Full-year FY27 EBITDA per ton guidance is maintained at ₹16,500 - ₹17,000, targeting gross profit per kg of ₹36-38. - Strategic initiatives include the commissioning of a 20,000 MTPA specialty black line in Mundra (total capacity 900,000 MTPA) and strong progress in advanced battery materials with Nanovace pilot plant trials starting in August. - A cost optimization program targets ₹200-250 Cr savings over 4-6 quarters. FY27 Capex is estimated around ₹300 Cr (+/- ₹50 Cr), primarily for efficiency. - Aquapharm reported Q1 FY27 revenue of ₹394 Cr and EBITDA of ₹47 Cr, with strong demand for green chelates and plans for a new facility. Expects to deliver better numbers in FY27, led by volume growth. - The company expects a tariff refund of ₹40-45 Cr from the US. Power business EBIT jumped 50% due to better realizations.

- PCBL Chemical Limited received an order from the Assistant Excise And Taxation Officer, Sonipat, Haryana, confirming a penalty of ₹6,08,400 under the GST Act, 2017. - The penalty is for a vehicle detention due to incomplete documents. - The company states there is no material financial or operational impact.

- Consolidated Revenue ₹2,473.37 Cr vs ₹2,114.05 Cr (▲17.00% YoY) - EBITDA ₹395.53 Cr vs ₹319.05 Cr (▲23.96% YoY) - PAT ₹154.93 Cr vs ₹94.10 Cr (▲64.64% YoY) - EBITDA Margin 16.00% vs 15.10% (▲90bps)

- The audio link for PCBL's Q1 FY27 Results Conference Call, held on July 29, 2026, at 17:00 hrs India Time, is now available on the company's website. - The call covered results for the quarter ended June 30, 2026. - The link can be accessed at www.pcblltd.com/investor-relation/financials/investor-presentation.

- Consolidated Revenue ₹2,473.37Cr vs ₹2,114.05Cr (▲17.00% YoY) - EBITDA ₹395.53Cr vs ₹319.05Cr (▲23.97% YoY) - PAT ₹154.93Cr vs ₹94.10Cr (▲64.64% YoY) - EBITDA Margin 15.99% vs 15.09% (▲90bps) - Interim Dividend declared @ 450% (₹4.50 per equity share) for the financial year ending March 31, 2027.

- Consolidated Revenue ₹2,473.37 Cr vs ₹2,114.05 Cr (▲17.00% YoY) - EBITDA ₹395.53 Cr vs ₹319.05 Cr (▲23.97% YoY) - PAT ₹154.93 Cr vs ₹94.10 Cr (▲64.64% YoY) - EBITDA Margin 16.0% vs 15.1% (▲90bps) - Interim Dividend of ₹4.50 per equity share (450%) declared for the financial year ending 31st March 2027.

- Consolidated Revenue ₹2,473.37 Cr vs ₹2,114.05 Cr (▲17.00% YoY) - EBITDA ₹395.53 Cr vs ₹319.05 Cr (▲23.97% YoY) - PAT ₹154.93 Cr vs ₹94.10 Cr (▲64.64% YoY) - EBITDA Margin 16.0% vs 15.1% (▲90bps) - Interim Dividend of ₹4.50 per equity share (450%) for FY27 declared, with August 4, 2026, as the Record Date.

- Mr. R K Agarwal ceased as an Independent Director of PCBL Chemical Ltd. due to term completion on July 25, 2026, also ceasing from the Audit and other committees. - Mr. Umang Kanoria was inducted as an Audit Committee Member on July 25, 2026, leading to the committee's reconstitution.

- Concall Schedule - Concall Date: Wednesday, July 29, 2026 - Concall Time: 17:00 hrs India Time - Purpose: To discuss the financial and operational performance for Q1FY27.

- PCBL Chemical Limited announced that CARE Ratings Limited has reaffirmed its credit ratings for the company's banking facilities. - Long term Bank Facilities (₹750 Cr) reaffirmed at CARE AA (Negative). - Long term / Short term Bank Facilities (₹3,815 Cr) reaffirmed at CARE AA(Negative) / CARE A1+. - Short term Bank Facilities (₹100 Cr) reaffirmed at CARE A1+.

- Trading window for Designated Persons and their immediate relatives of PCBL Chemical Limited will be closed from July 1, 2026. - It will remain closed until 48 hours after the declaration of Unaudited Financial Results for the quarter ending June 30, 2026.

- PCBL Chemical Limited commissioned a new specialty production line with a gross capacity of 20,000 MTPA at its Mundra plant in Gujarat. - This expands the total specialty production capacity to 132 KTPA, targeting high-growth, value-added printing segments and aims to improve margin profile.

New Filing detected. See link for details.

PCBL Chemical Limited will be participating in the 360 ONE Capital (B&K) Annual Investor Conference on May 28, 2026, and the ICICI Securities India Investor Conference 2026 on June 9, 2026, both to be held in Mumbai as physical investor group meetings. The company stated that no unpublished price sensitive information will be shared during these meetings.

PCBL Chemical Limited announced investor/analyst meets as per SEBI Regulation 30. The company will participate in the 360 ONE Capital (B&K) Annual Investor Conference on May 28, 2026, and the ICICI Securities India Investor Conference on June 9, 2026, both in Mumbai. No unpublished price sensitive information is proposed to be shared during these meetings.

PCBL Chemical Limited filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026, pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015. The report confirms that the company has complied with all applicable SEBI Regulations, with no non-compliances, deviations, or actions taken by SEBI/Stock Exchanges noted, and no resignation of statutory auditors during the review period.

PCBL Chemical Limited announced the successful passing of a Special Resolution via postal ballot and e-voting for the appointment of Ms. Sneh Lata (DIN: 11628402) as a Non-Executive Independent Woman Director. The resolution was passed with an overwhelming majority, with 94.21% of the total votes polled cast in favour, as per the results declared on May 8, 2026.

PCBL Chemical Limited's Q4 FY26 earnings call transcript indicates a positive outlook despite Q4 challenges from geopolitical conflicts and cost escalations. Management anticipates industry recovery within 2-3 quarters, driven by US tariff reductions, India-EU FTA, and customer restocking. The company expects robust high single-digit volume growth for its carbon black business in FY27 and more than double-digit EBITDA growth, with EBITDA per ton increasing by 14-15%. Cost reduction initiatives are projected to unlock INR200-250 crores savings over 4-6 quarters. The Nanovace battery chemicals pilot plant is ready for commissioning, offering high-growth diversification. Aquapharm is targeted to achieve an INR75 crore per quarter EBITDA run rate within 2-3 quarters. Net borrowings reduced by INR454 crores in FY26, and the long-term EBITDA guidance of INR 40 billion by 2030 remains on track.

Consolidated Revenue ₹1,392.36Cr vs ₹1,466.82Cr (▼5.1% YoY), EBITDA ₹164.87Cr vs ₹221.22Cr (▼25.5% YoY), PAT ₹53.77Cr vs ₹99.41Cr (▼45.9% YoY). EBITDA Margin 11.84% vs 15.08% (▼324bps).

PCBL Chemical Limited announced that the audio link for its Q4 FY26 Results Conference Call, held on April 30, 2026, for the quarter and financial year ended March 31, 2026, has been made available on the company's website.

New Filing detected. See link for details.

Standalone Revenue ₹1,371.07Cr vs ₹1,447.50Cr (▼5.28% YoY), EBITDA ₹157.12Cr vs ₹214.66Cr (▼26.71% YoY), PAT ₹47.02Cr vs ₹94.75Cr (▼50.37% YoY). EBITDA Margin 11.46% vs 14.83% (▼337bps).